Inventor · South San Francisco, CA, US

Adam P. Silverman

18Patents
4h-index
41Co-inventors
56Inventor score

Filing activity: Jan 18, 2010 → Apr 23, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US10870837B2 Fusion proteins comprising enzyme replacement therapy enzymes Chemistry; Metallurgy 9 Active
US11124567B2 Anti-TREM2 antibodies and methods of use thereof Chemistry; Metallurgy 7 Active
US10143187B2 Transferrin receptor transgenic models Physics 6 Active
US8778888B2 Cystine knot peptides binding to alpha IIb beta 3 integrins and methods of use Human Necessities 4 Active
US11970722B2 Engineered acid alpha-glucosidase variants Emerging Cross-Sectional Technologies 3 Active
US8741839B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin Human Necessities 2 Active
US11912778B2 Methods of engineering transferrin receptor binding polypeptides Chemistry; Metallurgy 2 Active
US11795232B2 Engineered transferrin receptor binding polypeptides Chemistry; Metallurgy 2 Active
US11866742B2 Fusion proteins comprising enzyme replacement therapy enzymes Chemistry; Metallurgy 2 Active
US9234021B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin Human Necessities 1 Active
US11124562B2 Anti-ApoE antibodies Chemistry; Metallurgy 1 Active
US11370832B2 Anti-Tau antibodies and methods of use thereof Chemistry; Metallurgy 1 Active
US12162948B2 Methods of engineering transferrin receptor binding polypeptides Chemistry; Metallurgy 1 Active
US9441026B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin Human Necessities 0 Active
US11926660B2 Anti-ApoE antibodies Chemistry; Metallurgy 0 Active
US11773185B2 Anti-BACE1 antibodies and methods of use thereof Chemistry; Metallurgy 0 Active
US9505822B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin Human Necessities 0 Active
US11612150B2 Transferrin receptor transgenic models Physics 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.